Cargando…
Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer
PURPOSE: The aim of this retrospective study was to investigate whether there are prognostically different subgroups among patients with pathologic N3 (pN3) breast cancer. METHODS: The records of 220 patients who underwent surgery for pN3 breast cancer from January 2006 to September 2012 were review...
Autores principales: | Kim, Yun Yeong, Park, Heung Kyu, Lee, Kyung Hee, Kim, Kwan Il, Chun, Yong Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929257/ https://www.ncbi.nlm.nih.gov/pubmed/27382392 http://dx.doi.org/10.4048/jbc.2016.19.2.163 |
Ejemplares similares
-
Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014) -
Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
por: Kim, Yun Yeong, et al.
Publicado: (2018) -
Prognostic significance of extranodal extension in patients with pathologic N1 non-small cell lung cancer undergoing complete resection
por: Yoon, Seung Keun, et al.
Publicado: (2023) -
Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014) -
The efficacy of oxidized regenerated cellulose (SurgiGuard(®)) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients
por: Nam, Kug Hyun, et al.
Publicado: (2022)